The global seasonal affective disorder therapeutics market is expected to grow at a 4.3% CAGR. The market is currently valued at US$ 848.2 million and is expected to reach US$ 1.1 billion by the end of 2028. Popular drugs preferred in seasonal affective disorder therapeutics include selective serotonin reuptake inhibitors (SSRIs), according to the report. While generics …
Tag Archives: Seasonal Affective Disorder Therapeutics Market Share
Seasonal Affective Disorder Therapeutics Market is Slated To Rise at a CAGR Of 4.3% during Forecast Period of 2022-2028
The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 848.2 million in 2022, with a modest Y-o-Y increase of 4.3% over 2022, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major …